Targeted Medical Pharma, Inc. reported consolidated earnings results for the third quarter and nine months ended September 30, 2013. For the nine months, the company reported total revenue of $6.9 million, an increase of 41% over the nine months ended September of 2012. Adjusted LBITDA was $2.4 million, an improvement of 36% over the $3.8 million reported nine months ended September of 2012. The company reported net loss of $9.8 million compared to $5.0 million for the last year.

For the quarter, the company reported total revenue of $2.2 million, an increase of 6% over the third quarter of 2012 and an increase of 14% over the second quarter of 2013. Adjusted LBITDA was $0.7 million, an improvement of 36% over the $1.1 million reported in third quarter of 2012 and an improvement of 55% over the second quarter of 2013. The company reported net loss of $1.7 million compared to $1.2 million for the last year.